Texas Case Counts
This page contains information and resources for Texas COVID-19 therapeutics providers. Providers with questions can contact therapeutics@dshs.texas.gov or call Provider Support at 833‑832‑7068, option 0.
On this page:
News & Updates
COVID-19 Therapeutics for High-Risk Patients
As a reminder, Texas has Paxlovid (ritonavir-boosted nirmatrelvir), which is the first line treatment per the NIH Treatment Guidelines for high-risk patients with symptomatic COVID-19 infection, stocked in pharmacies across the state of Texas. See the 6/29/22 DSHS communication to providers for more information.
More Provider Notices (PDFs)
Weekly eDigests (PDFs)
How to Become a COVID-19 Therapeutics Provider
To enroll as a therapeutics provider, please email therapeutics@dshs.texas.gov or call Provider Support at 833‑832‑7068, option 0.
Therapeutics Products
Click on any of the buttons below to access a list of product-specific resources.
For the latest information on product distribution across the state, see the Texas COVID-19 Product Availability section.
Monoclonal Antibody (mAb) Products
Bamlanivimab + Etesevimab (Lilly) Casirivimab + Imdevimab (Regeneron) Sotrovimab (GlaxoSmithKline) Bebtelovimab (Lilly)
Long-Acting Antibody (LAAB) Product
Evusheld: tixagevimab + cilgavimab (AstraZeneca)
Oral Antiviral Products
Lagevrio (molnupiravir) (Merck) Paxlovid: nirmatrelvir + ritonavir (Pfizer)
Important Links
Texas COVID-19 Product Availability
Job Aids & FAQs
Webinars
- DSHS Evusheld Webinar (2/11/2022): Dosage updated since webinar was recorded. Please see Evusheld Fact Sheet for Healthcare Providers for current dosage and indications.
- CDC COCA Call (6/16/2022): What Clinicians Need to Know About Available Therapeutic Options for COVID-19
- National Office Call Sessions: HHS / ASPR Allocation, Distribution, Administration of COVID-19 Therapeutics. Wednesdays 2:15-3:15 PM central. Please email COVID19Therapeutics@HHS.gov to request Zoom links for these calls.
- HHS COVID-19 Therapeutics Clinical Webinar: U.S. HHS hosts a roundtable on current COVID-19 topics every other Friday, 11:00 – noon central. Email COVID19Therapeutics@HHS.gov for more information on webinar dates and registration links.
- HHS Medical Professionals COVID-19 Roundtable: U.S. HHS hosts a roundtable on current COVID-19 topics every other Friday (opposite weeks from the therapeutics webinar above), 11:00 – noon central. Email COVID19Therapeutics@HHS.gov for more information on webinar dates and registration links.
Billing & Coding Information
▲ Top
This page is being updated as new information becomes available.